The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...
A new study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), which include popular weight loss drugs like ...
A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...
The reimbursement rates for many ASC procedures have benefited and will benefit under the new Medicare payment system. One such procedure seeing a noticeable reimbursement boost is endoscopy with ...
The company conducted a search of the health economics literature on balloon sinus dilation using XprESS or equivalent systems and functional endoscopic sinus surgery (FESS). This identified 134 ...
This new study, which followed patients up to 6 months after functional endoscopic sinus surgery, evaluated results using objective and subjective measures. “Nasal polyps are associated with ...
The committee concluded from the evidence presented that XprESS is a clinically non‑inferior, but less invasive, alternative to functional endoscopic sinus surgery (FESS) in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results